Back to Search Start Over

Acute EBV infection masquerading as 'In-situ Follicular Lymphoma': a pitfall in the differential diagnosis of this entity

Authors :
Anjum Hassan
Eric J. Duncavage
Alejandro A. Gru
John L. Frater
TuDung T. Nguyen
Friederike Kreisel
Source :
Diagnostic Pathology
Publication Year :
2013
Publisher :
BioMed Central, 2013.

Abstract

We present the case of a 30 year-old man who was referred for evaluation of diffuse lymphadenopathy. Six weeks prior, he noticed darkening of his urine associated with pale stools, nausea and an eventual 30 lb weight loss within a month. The initial laboratory findings showed elevation of the liver enzymes. A CT scan showed mesenteric and periaortic lymphadenopathy with the largest lymph node measuring 2.8 cm. Other laboratory results were otherwise unremarkable (including a normal LDH) with the exception of positive serum antibodies against Epstein-Barr virus (EBV) associated antigens (IgM+ and IgG+). An excisional biopsy of 4 of the small neck lymph nodes showed a normal architecture with prominent follicles and an intact capsule. But, by immunohistochemistry two of the follicles showed aberrant coexpression of BCL-2, in addition to CD10 and BCL-6. In-situ hybridization for early Epstein-Barr virus mRNA (EBER) and immunohistochemistry for latent membrane protein-1 (LMP-1) stained both scattered positive cells, as well as BCL-2 positive B-cells. Although an original diagnosis of in-situ follicular lymphoma was favored at an outside facility, additional interphase fluorescence in situ hybridization (FISH) studies for t(14;18);(IGH-BCL2) rearrangement (performed on the BCL-2 + follicles microdissected from the tissue block; Abott probe dual colour fusion) and molecular studies (IGH gene rearrangement by PCR, also performed on the microdissected follicles) were negative. Serologic studies (positive EBV antibodies) and immunostains in conjunction with the molecular studies confirmed the reactive nature of the changes. Our case also shows direct immunopathogenic evidence of BCL-2 expression among the EBV-infected cells, which has to our knowledge not been previously documented in vivo. A diagnosis of EBV infection should, therefore, be considered when confronted with BCL-2 expression in germinal centers, particularly in younger individuals, as the diagnosis of FLIS may lead to extensive and invasive haematologic work-ups. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/ 1323656318940068 Case report A 30 year-old man was referred for evaluation of diffuse lymphadenopathy. 6 weeks prior, the patient noticed darkening of his urine associated with pale stools, nausea and an eventual 30 lb weight loss within a month. He also complained of fever, myalgias, joint pain, and fatigue, which occurred approximately 48 hours after the onset of the urine colour changes. The initial laboratory results showed elevation of liver enzymes (AST 278 Units/L, ALT 831 Units/L and total bilirubin of 1.9 mg/dl). The complete blood count (CBC) included the following results: WBC 8.4 (neutrophils 54.5%, lymphocytes 34.3%, monocytes 7.8%, eosinophils 2.5% and basophils 0.9%), Hgb 15.9, hematocrit 47.3, platelet count 151, LDH 179, RBC 5.12 MCV 92.5 and RDW 13.2. An abdominal ultrasound revealed a 2.9 cm mass within the pancreas and the liver. A follow-up CT scan showed mesenteric and periaortic lymphadenopathy with the largest lymph node measuring 2.8 cm. Two weeks later, the majority of the symptoms resolved, but the patient noticed new enlarged lymph nodes in the right neck and in the left groin, measuring less than 1 cm. No associated hepatosplenomegaly was identified. The patient's admission laboratory results were otherwise unremarkable (including a normal LDH) with the exception of positive serum

Details

Language :
English
ISSN :
17461596 and 13236563
Volume :
8
Database :
OpenAIRE
Journal :
Diagnostic Pathology
Accession number :
edsair.doi.dedup.....5ddebf872c05db2ec6c6fc9407520df5